Found: 3
Select item for more details and to access through your institution.
The Group A Streptococcal Vaccine Candidate VAX-A1 Protects against Group B Streptococcus Infection via Cross-Reactive IgG Targeting Virulence Factor C5a Peptidase.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1811, doi. 10.3390/vaccines11121811
- By:
- Publication type:
- Article
Efficient production of immunologically active Shigella invasion plasmid antigens IpaB and IpaH using a cell-free expression system.
- Published in:
- Applied Microbiology & Biotechnology, 2022, v. 106, n. 1, p. 401, doi. 10.1007/s00253-021-11701-4
- By:
- Publication type:
- Article
Site-specific antigen-adjuvant conjugation using cell-free protein synthesis enhances antigen presentation and CD8+ T-cell response.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85709-1
- By:
- Publication type:
- Article